Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Protypia
Nashville, Tennessee, United Statesinotiv.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Protypia developed and provided a targeted proteomics platform using mass spectrometry to precisely quantify drug target systems in cells, tissue models, and human tissues. Their technology directly integrated protein-level pharmacology and pathology across multiple therapeutic areas, supporting the development of new immunotherapeutics for oncology and autoimmune diseases. The company was acquired by Inotiv in July 2022 for $11 million to enhance Inotiv’s bioanalytical capabilities, particularly in immuno-oncology and cell/gene therapy research support[1][2][5].
- Therapeutic areas
- OncologyImmunology
- Modalities
- ProteinPeptideLarge molecule (bioanalytical focus)
- Industry
- Contract Research Organization
02
Partnerships
Academic collaborations with leading institutions to advance MS protein analysis for drug discovery/resistance research[1]
Beyond the preview
Go deeper on Protypia.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Protypia.